StockData
Ascentage Pharma Group International logo

Ascentage Pharma Group International (AAPG) KPIs and segments

AAPGNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Apr 29, 2026Score 3/30
$13.14−0.15 (-1.13%)

Close on Nov 17, 2026Market cap $1.23BP/E –Yield –

KPIs & segments

Operating metrics and segments that drive Ascentage Pharma Group International's business

Ascentage Pharma Group International's revenue by segment, product and region, plus the counts and sizes it tags in its 10-K and 10-Q filings (XBRL). Each figure links to the filing it came from. A fuller KPI sheet built from earnings releases and presentations is on the way. See the segment tables for a trailing-twelve-month view, or how companies compare on operating metrics.

The chart is empty. Tick the box next to any metric in the table below to plot it — tick several to compare them on one chart.

Add to chartMetric
FY2025
FY2024
FY2023
FY2022
Intellectual Property(CN¥M)
678
Types of goods or services(CN¥M)
574981222210
Products(CN¥M)
499261194175
Others(CN¥M)
74.841.428.434.8
Switzerland(CN¥M)
678
Chinese Mainland(CN¥M)
574302222210
Earlier reporting (last reported 2022)1
Products(CN¥M)
453234164156
Others(CN¥M)
72.639.327.231.7

Italic numbers are calculated by StockData from reported figures (hover for the formula). Numbers with a dotted underline are read from the text of earnings releases and presentations; hover to see the exact sentence. Tick a row to add it to the chart above (up to 8 lines).

Methodology and excluded metrics
  • Core rows come from the segment and revenue-disaggregation notes of 10-K and 10-Q filings (XBRL), linked to each filing. Fourth-quarter figures are the fiscal year less the first nine months (shown in italic).

Data updated 2026-04-29.

See a number that looks wrong?